HB 1416
Referred to committee
Non-opioid treatment; terms; preferred drug lists; discretion; drug treatment; United States Food and Drug Administration; coverage; non-opioid drugs; reimbursement; effective date.
- Oklahoma
- House / Assembly
- Introduced Feb 3, 2025
- Session 2025
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
Oklahoma’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
16 actions-
Second Reading referred to Health and Human Services Committee then to Appropriations Committee
-
First Reading
-
Engrossed, signed, to Senate
-
Referred for engrossment
-
Third Reading, Measure passed: Ayes: 90 Nays: 7
-
Title stricken
-
Amended
-
Coauthored by Representative(s) Fugate
-
General Order
-
CR; Do Pass, amended by committee substitute Health and Human Services Oversight Committee
-
Authored by Senator Rosino (principal Senate author)
-
Policy recommendation to the Health and Human Services Oversight committee; Do Pass Public Health
-
Referred to Public Health
-
Second Reading referred to Health and Human Services Oversight
-
Authored by Representative West (Josh)
-
First Reading